Centenial Surgical Suture Ltd. is a medical device company, which engages in the manufacturing of surgical sutures and medical devices. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2005-09-16. The firm operates through the Medical Devices segment. The firm's products include atraumatic needles and sutures (absorbable and non-absorbable) and cardio blades. Its absorbable sutures consist of natural sutures and synthetic sutures, where natural sutures include Centenial-Catgut Plain, and Centenial-Catgut Chromic, and synthetic sutures include Centicryl Braided, Centicryl Rapid, Monosynth and Centisorb. Its non-absorbable sutures include Centilene, Centlon, Centsilk, Centibond, Centsteel and Centipace. Its medical devices include T-SUIT, Centilene Mesh, Skin Stapler, Centiclip, Aortic Punch and Kinfe. The company supplies technical specifications, including tables of dimensions and strength values, as well as chemicals and dye stuffs used in manufacturing each suture material.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.
11 fields couldn't be derived. The company was scraped before the cash-flow and balance-sheet rows were captured. Re-running an analysis will refresh these.